Milestone Scientific Inc. (NYSE:MLSS - Get Free Report) was down 4.1% during trading on Thursday . The stock traded as low as $0.90 and last traded at $0.92. Approximately 96,855 shares traded hands during trading, a decline of 44% from the average daily volume of 172,570 shares. The stock had previously closed at $0.96.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on MLSS. Benchmark reissued a "speculative buy" rating and issued a $1.25 target price on shares of Milestone Scientific in a research note on Wednesday, November 20th. StockNews.com initiated coverage on shares of Milestone Scientific in a research note on Saturday. They issued a "hold" rating for the company.
Check Out Our Latest Stock Analysis on Milestone Scientific
Milestone Scientific Trading Down 1.7 %
The company has a market cap of $70.88 million, a P/E ratio of -13.00 and a beta of 1.41. The company has a 50-day simple moving average of $1.13 and a 200 day simple moving average of $0.96.
Hedge Funds Weigh In On Milestone Scientific
A number of hedge funds have recently added to or reduced their stakes in MLSS. Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific in the 3rd quarter worth $48,000. Geode Capital Management LLC raised its holdings in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after acquiring an additional 31,572 shares in the last quarter. World Investment Advisors LLC purchased a new stake in Milestone Scientific in the third quarter worth about $91,000. Carnegie Investment Counsel grew its holdings in Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock worth $166,000 after acquiring an additional 27,412 shares in the last quarter. Finally, Renaissance Technologies LLC increased its position in Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares during the period. 5.79% of the stock is currently owned by institutional investors.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
